APOL1 and hypertensive disorder: Previous studies have highlighted ethical considerations of such testing,38 however strong support for testing has recently been reported among African Americans attending hypertension and nephrology clinics in the United States,39 and disclosure of high-risk APOL1 genotypes to hypertension patients has led to reductions in blood pressure and lifestyle changes such as improved dietary and exercise habits.40